drugset / Trial / NCT02607436

Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery Disease

NCT02607436

Phase 4 Completed 40 enrolled Seoul National University Bundang Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective interventional study to assess the effect of sarpogrelate compared with aspirin in Korean type 2 diabetic patients with atherosclerosis.

Timeline

Start
2015-07
Primary completion
2016-02
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule
Subject Sarpogrelate Small molecule